Provided by Tiger Trade Technology Pte. Ltd.

CEL-SCI Corp

1.42
-0.0400-2.74%
Post-market: 1.450.0300+2.11%19:57 EDT
Volume:66.12K
Turnover:96.57K
Market Cap:24.98M
PE:-0.55
High:1.49
Open:1.48
Low:1.42
Close:1.46
52wk High:13.48
52wk Low:0.8900
Shares:17.59M
Float Shares:16.95M
Volume Ratio:0.35
T/O Rate:0.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5688
EPS(LYR):-6.2655
ROE:-252.53%
ROA:-66.82%
PB:2.28
PE(LYR):-0.23

Loading ...

Norway's Zelluna ASA Reports Q2 Loss

Reuters
·
Aug 20

Accuray Q4 Revenue Falls as Tariff Concerns, Geopolitical Tensions Weigh on Demand

Reuters
·
Aug 20

Sweden's Cantargia Narrows H1 Loss, Raises SEK 132 Mln

Reuters
·
Aug 19

Germany's Immatics Q2 Revenue Rises but Misses Estimates

Reuters
·
Aug 18

SCI Shareholders Elect Directors at Annual Meeting

Reuters
·
Aug 17

CEL-SCI Q3 EPS $(0.47) Up From $(1.36) YoY

Benzinga Earnings
·
Aug 17

Cancer Immunotherapy Developer CEL-SCI's Q3 Net Loss Unchanged

Reuters
·
Aug 17

SCI FY26 Q3 Net Loss Narrows to USD 5.7 Million; Loss Per Share Improves to USD 0.47

Reuters
·
Aug 17

SCI Corporation Q2 EPS USD -0.47

THOMSON REUTERS
·
Aug 17

SCI Corporation Q2 Net Income USD -5.7 Million

THOMSON REUTERS
·
Aug 17

Press Release: CEL-SCI Reports Fiscal Third Quarter 2026 Results

Dow Jones
·
Aug 17

Press Release: Gerdau S.A. - Consolidated Information

Dow Jones
·
Aug 05

CEL-SCI announces publication of study supporting multikine biomarker strategy

TIPRANKS
·
Aug 04

SCI Study in Oral Oncology Flags Low PD-L1, N0 Oral Cancer Patients for Multikine Survival Benefit

Reuters
·
Aug 04

SCI Says Oral Oncology Accepts Multikine Phase 3 Data Showing Survival Benefit in Low PD-L1 Oral Cancer Patients

Reuters
·
Jul 30

First Berlin Reiterates Buy on Cel-sci, Cuts Price Target to USD 15

Reuters
·
Jul 20

Ecopetrol's Acquisition Appeal Backed by Brazilian Regulator, Reviving Takeover Process

Deep News
·
Jul 17

Press Release: Ecopetrol Reports CVM Decision on Appeal Related to the Tender Offer

Dow Jones
·
Jul 16

SCI Notifies Availability of Multikine Phase 3 Confirmatory Study Launch Release

Reuters
·
Jul 13

SCI Corp - to Launch Phase 3 Confirmatory Study for Multikine in Head and Neck Cancer

THOMSON REUTERS
·
Jul 13